Botox and Altace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Botox (botulinum toxin type a) and Altace (ramipril). Common drug interactions include alopecia among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Botox and Altace. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

On Jul, 07, 2026

12 people who take Botox and Altace together, and have interactions are studied.

What are the common drug interactions of Botox and Altace, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Decreased appetite
Drooling (drop saliva uncontrollably from the mouth)
Dysphagia (a condition in which swallowing is difficult or painful)
Nausea (feeling of having an urge to vomit)
Ageusia (loss of taste functions of the tongue)
Anosmia (partial or complete loss of the sense of smell)
Anxiety
Cardiomyopathy (weakening of the heart muscle)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

male:

Depression
Dry mouth
White blood cell count increased
Hypokinesia (decreased bodily movement)
Lethargy (tiredness)
Local swelling (swelling at the site of some application of substance or injury)
Lymphadenopathy (disease or enlargement of lymph nodes)
Mass
Muscular weakness (muscle weakness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the common drug interactions of Botox and Altace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Diabetes mellitus inadequate control
Diabetic coma
Pancreatitis (inflammation of pancreas)
Therapeutic response decreased (less preventive response)
Type 2 diabetes mellitus

50-59:

Haemoglobin decreased
Haemorrhage (bleeding)
Injection site bruising
Injection site erythema (redness at injection site)
Neoplasm (tumour)

60+:

Alopecia (absence of hair from areas of the body)
Lethargy (tiredness)
Drooling (drop saliva uncontrollably from the mouth)
Drug ineffective
Dry mouth
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Erythema (redness of the skin)
Headache (pain in head)
Hypokinesia (decreased bodily movement)

What are the existing conditions these people have? *

Skin Wrinkling (wrinkle on skin): 2 people, 16.67%
Pain: 2 people, 16.67%
Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 1 person, 8.33%
Hyperhidrosis (abnormally increased sweating): 1 person, 8.33%
Hot Flush (sudden feelings of heat): 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Botox and Altace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously